Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novatarg
AddedFeb 17, 2024
UpdatedJun 18, 2026
Novatarg

Novatarg

NovaTarg Therapeutics: A private pharma firm specializing in tissue-targeted drug discovery.

HQ
Durham, NC, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

NovaTarg Therapeutics, a privately owned pharmaceutical company, was founded with the mission to revolutionize drug discovery through the development of tissue-targeted medicines. The company leverages its leadership team's extensive experience in drug discovery to create innovative therapeutic solutions. NovaTarg's primary focus is on the development of NT1195, a promising candidate in their pipeline aimed at addressing specific tissue-related medical conditions.

NovaTarg Therapeutics has garnered attention for its novel approach and has established itself as a key player in the pharmaceutical industry. The company's leadership includes seasoned experts in drug discovery, contributing to its strategic direction and success. NovaTarg's pioneering work in tissue-targeted therapies has the potential to significantly impact patient outcomes, positioning it as an influential entity in the realm of precision medicine.

Novatarg - Similar Companies

Novita Therapeutics logo

Novita Therapeutics

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Novel Therapeutic Technologies logo

Novel Therapeutic Technologies

ntt-inc.com

Navitor Pharmaceuticals logo

Navitor Pharmaceuticals

Ventrinova logo

Ventrinova

Novoron Bioscience logo

Novoron Bioscience

novoron.com

NovaDerm Aid logo

NovaDerm Aid

OncoTartis logo

OncoTartis

NanoPharmaceuticals logo

NanoPharmaceuticals

Novagenic logo

Novagenic

novagenic.com

Novasenta logo

Novasenta

novasenta.com

Denovo Biopharma logo

Denovo Biopharma

Nerx Biosciences logo

Nerx Biosciences

Nexo Therapeutics logo

Nexo Therapeutics

nexotx.com

NovoThelium logo

NovoThelium

novothelium.com

Novatarg - Quick Facts

Who are Novatarg's competitors?

Companies similar to Novatarg include Novita Therapeutics, Novita Pharmaceuticals, Novel Therapeutic Technologies and Navitor Pharmaceuticals.

When was Novatarg founded?

Novatarg was founded in 2009.

Where is Novatarg's headquarters located?

Novatarg's headquarters is located in Durham, NC, US.

When was Novatarg's last funding round?

Novatarg's most recent funding round was for $3.2M (USD) in September 2015.

How much has Novatarg raised to-date?

As of Sep 29, 2015, Novatarg has raised a total of $3.2M (USD).

How many employees does Novatarg have?

Novatarg has 5 employees as of Feb 4, 2024.

Novatarg - Classification

Ownership
  • Private
Technology
  • Biotech
Revenue
  • Recurring
Main Product
  • Pharmaceuticals
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified